Skip to main content
  • Notices

Lunch Talk Session in Collaboration with HERALBONY (for N&A members)

On Oct. 28, 2025, we hosted a lunchtime talk session with Takaya Matsuda, Co–CEO of HERALBONY Co., Ltd., our client and organizer of the “HERALBONY Art Prize 2025” which our firm sponsored. We also welcomed Yujin Gen, Executive Officer and Chief Legal Officer (CLO) of HERALBONY.

The session highlighted the shared social goals pursued by each of HERALBONY and our firm. The opportunity provided members of Nishimura & Asahi with an opportunity to consider the broader impact of our legal support to reaffirm the significance of their roles.

People

中山 龍太郎

Ryutaro Nakayama specializes in General Corporate and M&A work, and advises clients on a broad range of issues and transactions relating to M&A, Japanese corporate, securities, tax, and merger control laws, and regulations specific to various industries. He is a leading lawyer in the field of competition law in Japan, and possesses a unique set of skills and experience, drawn from his extensive experience handling M&A, corporate, and merger control cases and transactions. He has obtained transaction clearances from competition authorities even where the resulting combined market share exceeded 50% in the relevant markets. He has led Nishimura & Asahi’s Africa Practice Team since its formation in 2014. He has established a strong network of connections with Japanese entrepreneurs and businesses that target the African continent, as well as with leading law firms based in Africa. He has been named a leading lawyer in the fields of Corporate/M&A and/or competition law by various publications, including Chambers Global, Chambers Asia-Pacific, and The Nikkei’s annual rankings of “Most Successful Lawyers.” He was appointed the Managing Partner of Nishimura & Asahi in April 2021.

犬塚 有理沙

Alisa Inuzuka advises clients in the life science and healthcare industries on matters including pharmaceuticals, medical devices, in vitro diagnostics, cosmetics, health foods, medical systems, and laboratory tests. In addition, she has experience in M&A, regulatory advice, reviewing and drafting various contracts, and crisis management and investigation, as well as communicating with the relevant authorities in these areas. She also supports non-healthcare companies in entering into the healthcare industry as well as the entry of non-Japanese healthcare companies into the Japanese market. She seeks to contribute to enhancing people’s health and lives by working to maximize clients’ business opportunities.

山本 晃久

Akihisa is a partner in our M&A team. He handles many domestic and international M&As, business alliances including JVs, business succession, equity finance, and hostile takeovers. He has abundant practical experience for both listed and unlisted companies and wide range of company sizes and transaction types, knowledge of cutting-edge practical trends and laws and regulations, and the ability to respond flexibly and hands-on.
In addition, he active in start-up finance support, IPO support, and daily legal support.
Recently, using the network and knowledge cultivated through studying abroad in Europe and the United States, he also deals with sustainability-related topics such as sustainable finance, including ESG investment and impact investment, social enterprise, B Corp certification, and social IPO.